stockrow
Saturday 7 November 2026
Export DMRA’s income statement to Excel — free account
Galecto, Inc.
DMRA Healthcare Biotechnology
- EPS
- +78.1%
- Free cash flow
- −877.5%
Quarter to September 2026, against a year earlier
23.67
1.81
+8.28%
Follow DMRA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
6.72% | (12.37%) | (26.26%) | (39.51%) | |
| (3.90%) | (8.79%) | (18.64%) | (27.08%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(2.25%) | (4.73%) | (10.07%) | (14.85%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(4.93) | (0.73) | (0.73) | (0.96) | |
Free Cash Flow |
(6.73) | (24.88) | (44.51) | (59.13) | |
| Other line items | |||||
Cash ROIC |
(1.35%) | (2.38%) | (4.21%) | (5.77%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.24 | 1.03 | 0.86 | 0.80 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.93) | (0.73) | (0.73) | (0.96) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026